Friday, September 21, 2007 8:11 pm | 
|
Novartis Pharma makes move to end addiction of depression drug
A pharmaceutical company plans to end health insurance coverage for the stimulant drug Ritalin in treating depression because widespread abuse of the system by patients and doctors has led to a number of addictions.
[ASAHI]
Related posts
Astellas seeks to expand transplant drug use in Japan Okinawa Assembly makes new move against deletion of wartime suicides in textbooks U.S. nonmilitary staffer arrested over drug use Banned drug found in eel from China Patient dies after being given triple dose of anticancer drugJapan News Review
© All rights reserved
None found
While low-cost carriers have since long been successfully operating throughout the U.S., Europe, and southern Asia, Japan has seen very little of the low-price action.
